Related Experiment Video
Updated: May 23, 2025

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
Inferring active mutational processes in cancer using single cell sequencing and evolutionary constraints
Gryte Satas1,2, Matthew A Myers1,2, Andrew McPherson1,2
1Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ultra-low-coverage single-cell whole-genome sequencing (scWGS) can distinguish active from historical cancer mutational processes. This method reveals dynamic mutational patterns linked to tumor evolution and therapeutic resistance.
Area of Science:
- Genomics
- Cancer Biology
- Evolutionary Biology
Background:
- Cancer's natural history is shaped by ongoing mutagenesis, creating genetic diversity.
- Distinguishing active from historical mutational processes is crucial for understanding tumor evolution, presentation, and therapeutic resistance.
- Bulk sequencing typically captures only historical mutational signatures, limiting insights into dynamic processes.
Purpose of the Study:
- To investigate if ultra-low-coverage single-cell whole-genome sequencing (scWGS) can differentiate between historical and active mutational processes in cancer.
- To develop a method for robustly analyzing single nucleotide variants (SNVs) in sparse scWGS data.
- To uncover temporal and spatial patterns of mutagenesis in various cancer types.
Main Methods:
- Introduced ArtiCull, a novel method to identify and remove SNV artifacts in scWGS data by utilizing evolutionary constraints.
- Applied ArtiCull to analyze scWGS data from pancreatic ductal adenocarcinoma (PDAC), triple-negative breast cancer (TNBC), and high-grade serous ovarian cancer (HGSOC).
- Examined mutation patterns in therapy-treated and untreated cancer models to identify active mutational signatures.
Main Results:
- Demonstrated that scWGS data, despite sparsity, contains valuable information on dynamic mutational processes.
- Observed a temporal increase in mismatch repair deficiency (MMRd) in PDAC.
- Identified therapy-induced mutagenesis and APOBEC3 inactivation in cisplatin-treated TNBC xenografts.
- Revealed distinct APOBEC3 mutagenesis patterns and late tumor-wide activation in HGSOC.
- Detected clone-specific increases in SBS17 activity associated with recurrence in HGSOC.
Conclusions:
- Ultra-low-coverage scWGS is a powerful tool for studying active mutational processes in cancer.
- This approach can provide insights into ongoing clonal evolution and mechanisms of therapeutic resistance.
- Findings highlight the potential of scWGS for dissecting dynamic mutagenic landscapes in diverse cancers.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Evolutionary Relationships through Genome Comparisons
Synteny and Evolution
Around 80 million years ago, the human and mice lineages diverged from the common ancestor. During the course of evolution, the ancestral...
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Gene Evolution - Fast or Slow?
In contrast, regions which code...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

